Qiagen Launches $750M Convertible Bonds Offering, Expands Sample to Insight Solutions

Qiagen NV is launching a $750 million convertible bonds offering. The company, based in the Netherlands, provides Sample to Insight solutions that transform biological samples into molecular insights through sample and assay technologies, bioinformatics, and automation systems. The offering aims to raise funds for further growth and development of its Sample to Insight solutions.

QIAGEN NV, a Netherlands-based biotechnology company, has announced a $750 million convertible bonds offering. The company, which provides Sample to Insight solutions that transform biological samples into molecular insights, aims to raise funds for further growth and development of its Sample to Insight solutions.

The bonds, which will be issued in minimum denominations of $200,000 each, will be settled in USD and issued in reliance on Regulation S through a private placement to institutional investors outside the United States, Australia, South Africa, and Japan. The bonds will have a maturity of 7 years and will be issued at par with interest rates ranging from 1.75% to 2.25% per annum, payable semi-annually in arrear. The bonds will be redeemable at par plus accrued interest at maturity or under certain conditions.

Holders of the bonds will have the option to convert them into ordinary shares of the company at a premium over the current share price. The initial conversion price is expected to be set at a 40% to 45% premium over the reference share price, which will be equal to the volume-weighted average price of the shares on the New York Stock Exchange on August 28, 2025. The bonds are expected to be admitted to trading on the Open Market (Freiverkehr) segment of the Frankfurt Stock Exchange.

QIAGEN intends to use the net proceeds from the issuance of the bonds for general corporate purposes, including the refinancing of existing indebtedness. The company expects to use the funds to support its ongoing research and development efforts, as well as to expand its Sample to Insight solutions.

The offering is being led by BNP PARIBAS, BofA Securities, and Goldman Sachs Bank Europe, acting as Joint Global Coordinators and Joint Bookrunners alongside Deutsche Bank Aktiengesellschaft, Jefferies, and Moelis & Company.

References:
[1] https://www.businesswire.com/news/home/20250827734204/en/QIAGEN-N.V.-Launches-Non-US-Offering-of-Net-Share-Settled-Convertible-Bonds